Chemoinformaics analysis of Matteucinol-7-Rhamnoside
| Molecular Weight | 460.479 | nRot | 4 |
| Heavy Atom Molecular Weight | 432.255 | nRig | 24 |
| Exact Molecular Weight | 460.173 | nRing | 4 |
| Solubility: LogS | -3.833 | nHRing | 2 |
| Solubility: LogP | 3.562 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 12 |
| nHA | 9 | APOL | 65.9682 |
| nHD | 4 | BPOL | 35.9018 |
| QED | 0.54 |
| Synth | 4.123 |
| Natural Product Likeliness | 2.024 |
| NR-PPAR-gamma | 0.229 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.031 |
| Pgp-sub | 0.988 |
| HIA | 0.009 |
| CACO-2 | -5.877 |
| MDCK | 0.000013 |
| BBB | 0.092 |
| PPB | 0.945786 |
| VDSS | 1.018 |
| FU | 0.0510992 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.676 |
| CYP2c19-inh | 0.207 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.346 |
| CYP2c9-sub | 0.836 |
| CYP2d6-inh | 0.286 |
| CYP2d6-sub | 0.379 |
| CYP3a4-inh | 0.279 |
| CYP3a4-sub | 0.261 |
| CL | 5.645 |
| T12 | 0.143 |
| hERG | 0.044 |
| Ames | 0.172 |
| ROA | 0.661 |
| SkinSen | 0.797 |
| Carcinogencity | 0.163 |
| EI | 0.073 |
| Respiratory | 0.597 |
| NR-Aromatase | 0.809 |
| Antiviral | Yes |
| Prediction | 0.962476 |